1. Home
  2. ADN vs TSBX Comparison

ADN vs TSBX Comparison

Compare ADN & TSBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADN
  • TSBX
  • Stock Information
  • Founded
  • ADN 2006
  • TSBX 2015
  • Country
  • ADN United States
  • TSBX United States
  • Employees
  • ADN N/A
  • TSBX N/A
  • Industry
  • ADN Power Generation
  • TSBX
  • Sector
  • ADN Utilities
  • TSBX
  • Exchange
  • ADN Nasdaq
  • TSBX Nasdaq
  • Market Cap
  • ADN 6.6M
  • TSBX 7.7M
  • IPO Year
  • ADN N/A
  • TSBX 2023
  • Fundamental
  • Price
  • ADN $2.90
  • TSBX $0.36
  • Analyst Decision
  • ADN
  • TSBX Buy
  • Analyst Count
  • ADN 0
  • TSBX 3
  • Target Price
  • ADN N/A
  • TSBX $4.75
  • AVG Volume (30 Days)
  • ADN 23.4K
  • TSBX 628.3K
  • Earning Date
  • ADN 12-27-2024
  • TSBX 05-08-2025
  • Dividend Yield
  • ADN N/A
  • TSBX N/A
  • EPS Growth
  • ADN N/A
  • TSBX N/A
  • EPS
  • ADN N/A
  • TSBX N/A
  • Revenue
  • ADN $3,276,000.00
  • TSBX N/A
  • Revenue This Year
  • ADN $2,232.99
  • TSBX N/A
  • Revenue Next Year
  • ADN $91.56
  • TSBX N/A
  • P/E Ratio
  • ADN N/A
  • TSBX N/A
  • Revenue Growth
  • ADN 274.35
  • TSBX N/A
  • 52 Week Low
  • ADN $1.71
  • TSBX $0.29
  • 52 Week High
  • ADN $8.79
  • TSBX $3.05
  • Technical
  • Relative Strength Index (RSI)
  • ADN 55.41
  • TSBX 56.52
  • Support Level
  • ADN $2.52
  • TSBX $0.32
  • Resistance Level
  • ADN $2.74
  • TSBX $0.38
  • Average True Range (ATR)
  • ADN 0.26
  • TSBX 0.03
  • MACD
  • ADN 0.07
  • TSBX 0.00
  • Stochastic Oscillator
  • ADN 84.51
  • TSBX 78.89

About ADN Advent Technologies Holdings Inc.

Advent Technologies Holdings Inc is an innovation-driven company in the fuel cell and hydrogen technology space. The company develops, manufactures, and assembles complete fuel cell systems and the critical components that determine the performance of hydrogen fuel cells and other energy systems. It serves automotive; aviation and power generation industries. It generates revenue from the sale of fuel cell systems and the sale of MEAs, membranes, and electrodes for specific applications in the fuel cell and energy storage (flow battery) markets.

About TSBX Turnstone Biologics Corp.

Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company is pioneering a differentiated approach to tumor-infiltrating lymphocytes, or TILs, a clinically validated technology for treating solid tumors. It is developing next-generation TIL therapies by selecting the most potent and tumor-reactive T cells, which are referred to as Selected TILs. TILs are a type of cell therapy that harnesses the patient's own immune cells to target their own tumors. TIL therapy involves the isolation of lymphocytes from the patient's tumor, expansion of the isolated cells outside the body, and then infusion of the cells back into the patient.

Share on Social Networks: